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As an intern, I took care of the fi rst patients with HIV/AIDS at San Francisco General Hospital, 
and so I grew up with AIDS in the early 
days of my medical career. We struggled 
through the confusion about what was 
making people so sick, and each new 
day brought a new discovery about the 
disease and its consequences. I went 
through that evolutionary process along 
with everybody else, and it shaped me 
in many profound ways. Before long, 
I recognized that this wasn’t a disease 
of “those people over there.” This was 
a disease that could strike anyone, 
anytime. And as physicians, we had 
to adjust our thinking about our own 
vulnerability to occupational risk, and 
to emphasize prevention, because there 
wasn’t going to be a cure for a long, 
long while. And not only physicians had 
to rethink things—AIDS has reshaped 
society’s very notions of the most basic 
human behaviors. 
I was in Uganda in 1985, early in the 
AIDS epidemic there. We knew then 
where that epidemic was going to go, 
absent an effective vaccine or cure, 
but few of us could have imagined 
that it would evolve so quickly without 
an end in sight.  While the people of 
Africa have achieved a huge amount 
in tackling HIV/AIDS, particularly in 
Uganda, the epidemic is far from being 
under control on that continent and is 
spreading through other parts of the 
world with alarming speed. 
The Crisis of Human Resources 
The theme of this year’s International 
AIDS Conference in Bangkok was 
“Access for All.” Over the past few 
years, it has become increasingly 
apparent that a critical component of 
assuring access to care and treatment 
is human capital. Like fi scal capital, 
human resources are essential to 
ending the AIDS pandemic. I visited 
Africa with US Health and Human 
Services Secretary Tommy Thompson 
and many AIDS experts last December, 
and we saw evidence of this critical 
need in every country we visited. 
The miracles of modern science are 
meaningless without systems and 
people to deliver them to those in 
need. 
The World Health Organization 
estimates that of the 40 million people 
worldwide infected with HIV, 6 million 
need immediate, life-sustaining 
antiretroviral therapy. Fewer than 
400,000 people in developing countries 
have access to such treatment (Figure 
1) [1,2]. There are too few skilled 
health care workers to provide reliable 
delivery and administration of these 
life-saving therapies. According to a 
recent Institute of Medicine report, and 
a study sponsored by the US Agency 
for International Development, the 
number of health care workers in many 
African countries is actually shrinking 
as they are lured to developed 
countries by better pay and professional 
opportunities (Box 1) [2,3]. Reversing 
this brain drain is essential over the 
long-term, as HIV treatment and care 
will be required for decades. In the 
short-term, the Institute of Medicine 
called for expanded efforts “to bring 
qualifi ed volunteer initiative medical 
professionals into both urban and rural 
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Figure 1. Estimated Percentage of Adults in Need of Antiretroviral Treatment Who Are Receiving It, 
as of March of 2004
(This graphic is based on an image by the World Health Organization, available at 
http:⁄⁄www.who.int/3by5/en/coverage_march2004.jpg)
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areas to support prevention, care, and 
training programs” [2]. I could not 
agree more that addressing the human 
resource needs will be essential as we 
move forward—and not just for HIV/
AIDS programs, but for all aspects of 
public health and health care. 
It has now been shown, beyond 
any doubt, that even in resource-
poor countries with the most basic 
health infrastructure, people get the 
same benefi t from treatment and 
prevention interventions as those in 
the rich world [4]. In fact, surveys in 
Cape Town, Kampala, Khayelitsha, 
and Senegal found rates of adherence 
to antiretroviral therapy of 90%–94%, 
compared with estimates of 70% in 
developed countries [5,6,7].
When You Have Seen the Faces 
We hear the numbers—the millions 
upon millions infected—and we grow 
numb. That is why we must go to 
the front lines—the households and 
communities—and start focusing on 
each individual living with HIV. I was 
at the dedication of an AIDS clinic 
in Kenya. It was raining, and we were 
waiting outside with our umbrellas. A 
12-year-old girl in front of me turned 
around and leaned her head against 
my belly and said, “Could you take 
me to America? I need drugs.” If you 
take that girl’s face and multiply it a 
thousand times—that is the memory I 
bring home from Africa: the faces of 
the children and their asking, “Why are 
so many of our parents dying? Why are 
we dying?” 
We visited a US Centers for Disease 
Control and Prevention (CDC) 
program in the very remote areas of 
Uganda where there are no roads and 
it is impossible for people to come 
into population centers to receive 
HIV testing and other services. Young 
staff from the CDC are working 
with Ugandans and community 
organizations in that area to deliver 
antiretroviral therapy. Some may 
think that the diffi culties of delivering 
antiretroviral therapy into such a 
remote area are overwhelming—and 
some may question whether this is a 
sustainable intervention. But once 
you see fi rsthand what miracles are 
possible, your world view changes 
almost overnight.
What we saw was the success of a 
wonderful home-based treatment and 
care program for people who don’t 
have access through other means. 
And when I say “home-based care,” 
picture a hut without running water 
or electricity, where only motorcycles 
are available to deliver medications. 
The fi rst step of the program is to 
provide clean water. Coliforms and 
other pathogens in the water supply for 
the household are removed through 
an inexpensive water vessel fi tted with 
a fi lter and through a chlorination 
process. In addition, a cotrimoxazole 
tablet is given every day, which, in 
one patient’s words, changed his 
life because he began to feel well 
almost immediately. Not only do the 
cotrimoxazole prophylaxis and the 
water treatment improve diarrheal 
illness, but malarial parasitemia 
also drops. So that is a very positive, 
unexpected consequence of just 
two very simple and inexpensive 
interventions. Many patients with HIV/
AIDS in Africa also have tuberculosis 
and are put on tuberculosis therapy in 
addition to cotrimoxazole. As a result, 
they begin to feel better even before 
they begin antiretroviral therapy.
We spent time with one of the 
patients in the home-based care 
program. As she began to participate 
in these programs, tests became 
available to measure her CD4 count. 
She explained to me what her CD4 
count was, what it meant, and how 
it improved when she started the 
cotrimoxazole and tuberculosis 
therapy. She had begun taking three 
antiretroviral drugs and held up her 
pill box to explain her regimen in 
detail. Every week a Ugandan health 
aide delivered her supply of pills on a 
CDC motorcycle and monitored her 
adherence to the treatment. Not only 
was she extremely reliable in taking 
her medications, but she also knew 
more about them and their side effects 
than most of the patients I treated at 
San Francisco General. She was also an 
expert in HIV prevention. I asked her, 
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Box 1. The Brain Drain: Facts 
and Figures [2,3]
• Only 360 of the 1,200 doctors trained in 
Zimbabwe during the 1990s continue to 
practice within the country.
• Two-thirds of University of Zimbabwe 
medical students intend to leave the 
country after graduating, and one of 
the country’s major 1,000-bed teaching 
hospitals lacks a single qualifi ed 
pharmacist.
• In Zambia, only 50 of the 600 doctors 
trained locally since independence have 
remained in the country.
• In Ghana, 320 nurses are recorded 
to have been lost in 1999, roughly 
equivalent to that country’s annual 
output of nurses; losses for the year 2000 
totaled 600.
DOI: 10.1371/journal.pmed.0010010.g002
Behavior change club at a technical school in Entebbe, Uganda
(Photo: Arjen van de Merwe/World Population Foundation)
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“What do you do to protect your three 
young sons from this infection?” She 
replied, “Every day I take them by the 
hand, and I go out of the house and 
I say, ‘Do you see that mound of dirt? 
That is your father’s grave. Your father 
acquired this fatal infection through 
sex. Be careful.’” And then she talks 
to them about the “ABCs” (“A” for 
abstinence, “B” for being faithful, “C” 
for condoms). 
So when you see a story like that 
unfold in the middle of Africa, it’s 
impossible not to be hopeful. And yet, 
it’s also very sobering because we are 
reminded of our responsibility. The 
question is not what the international 
health community is accomplishing 
in these countries now, but what we 
could accomplish if we joined together 
to really fi ght this war on AIDS. Such 
a story also inspires hope because you 
can see the multiplier effect that comes 
from taking on one problem and can 
see the way that effort can expand to 
encompass and address a much greater 
set of problems. 
Beyond ABCs—Diagnosis 
and Responsibility
When we think about successful 
prevention models in Uganda, “ABC” 
certainly stands out [8]. However, at 
this point in the epidemic curve, other 
letters must also be considered. Most 
HIV transmission is accounted for by 
infected people having risky sex with 
uninfected people. Both in the US 
and in Africa, studies show that most 
infected people engaging in risky 
sex are unaware of their infection 
status, and that when their infection 
is diagnosed, they usually take steps to 
protect the others with whom they are 
having contact [9,10,11,12]. So let’s 
add the letter “D” for diagnosis. In 
fact, improving efforts to help people 
choose risk avoidance and to diagnose 
those who are already infected is the 
cornerstone of the CDC’s new domestic 
HIV prevention strategy. Diagnosis is 
extremely important in many African 
communities, especially where the 
number of discordant couples—where 
one individual is infected and the 
other is not—is high. Sadly, many 
couples “being faithful” now do not 
realize that one partner is already 
infected and are not being reached 
with diagnostic testing programs. So 
“ABCD” is a concept that I would like 
to put out on the table as food for 
thought. Of course, there is another 
letter that we need to stress: the letter 
“R,” for responsibility:  personal sexual 
responsibility is a critical component 
of HIV prevention. Many women 
and girls become infected after 
being raped by men or because their 
social circumstances rob them of the 
power to refuse sex. Men must be 
held accountable for greater sexual 
responsibility and for ending sexual 
violence and degradation of women 
and girls. HIV prevention programs 
need to emphasize responsibility, 
but not lose sight of the fact that 
responsibility can be practiced only 
with personal autonomy, which many 
women and girls simply do not have. 
Expanding the Team to Meet 
the Needs
The innovative programs and ideas 
emerging in Africa can change the 
picture of the AIDS epidemic. The 
purchase of antiretroviral drugs for 
Africans is not the big challenge. Access 
to drugs will improve in Africa. The 
real challenges are delivering drugs in 
a safe and effective way, monitoring 
therapy, and sustaining the pipeline 
of drugs so that ongoing treatment 
can be guaranteed. In the example of 
the home-based program in Uganda, 
we have seen that these challenges 
can be overcome. Expanding access 
to prevention, care, and treatment 
services isn’t going to be easy, but 
it is certainly possible. It will take 
unprecedented commitment by people 
in the public sector, the private sector, 
faith communities, and community 
organizations, and perhaps most 
importantly, individual volunteers who 
make up their minds to contribute in 
any way they can.
Last fall, the US Peace Corps 
announced that it was activating 
programs in some countries that 
allow volunteers to help communities 
fi ght the AIDS epidemic, but this is 
just one of many steps that are being 
taken. The US president’s Emergency 
Plan for AIDS Relief will provide 
$15 billion, including almost $10 
billion in new funds, over fi ve years 
for international AIDS assistance 
[13], and I am part of the team that 
is charged with making this plan 
happen. I look forward to learning 
from others in the global health 
community how we can best expand 
our impact and collectively fi nd a way 
to support the delivery of prevention 
messages and life-saving medications 
to everyone in Africa—and especially 
to that little girl at the Kenyan clinic 
who touched my heart. 
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